Filter
1338
Filtered Results: 1338
Text search:
European
Monitoring
Centre
for
Drugs
and
Drug
Addiction
Featured
Recommendations
119
New Publications
255
Language
Document type
No document type
728
Studies & Reports
294
Guidelines
164
Manuals
75
Strategic & Response Plan
39
Fact sheets
17
Situation Updates
10
Training Material
8
Resource Platforms
3
Countries / Regions
Western and Central Europe
93
Global
63
Eastern Europe
41
Ukraine
33
India
33
Africa
24
Kenya
23
Sierra Leone
21
Uganda
20
Latin America and the Carribbean
16
Nigeria
15
Ethiopia
15
Russia
14
Zambia
14
Liberia
14
Myanmar / Burma
14
Ghana
13
South Africa
13
Nepal
12
Philippines
12
Eastern Europe and Central Asia
11
Albania
9
Tanzania
9
Tajikistan
8
Zimbabwe
8
West and Central Africa
8
Namibia
8
Georgia
8
Syria
7
Malawi
7
Cambodia
7
South–East Asia Region
7
East and Southern Africa
7
Thailand
6
Lesotho
6
Rwanda
6
Asia
6
Bangladesh
6
North Macedonia
5
Senegal
5
Burkina Faso
5
Germany
5
Congo, Democratic Republic of
5
Middle East and North Africa
5
Laos
4
Mozambique
4
Vietnam
4
Brazil
4
Moldova
4
Eswatini/ Swaziland
4
Iran
3
Guinea
3
Armenia
3
USA
3
Jordan
3
Western Pacific Region
3
Jamaica
3
Lebanon
3
Sudan
3
South Sudan
3
Iraq
3
Pakistan
3
Colombia
2
Mexico
2
Turkey
2
Cameroon
2
Estonia
2
Kyrgyzstan
2
Morocco
2
Venezuela
2
Belgium
2
United Kingdom
2
Portugal
2
Belarus
2
Sri Lanka
2
Botswana
2
Indonesia
2
Somalia
2
Serbia
1
Benin
1
Kazakhstan
1
Fiji
1
Uzbekistan
1
Afghanistan
1
Peru
1
Qatar
1
Bulgaria
1
Italy
1
Haiti
1
Hungary
1
Lithuania
1
Ireland
1
Saudi Arabia
1
North America
1
Gabon
1
Turkmenistan
1
Denmark
1
France
1
Tunisia
1
Norway
1
Spain
1
Argentina
1
Greece
1
Central African Republic
1
Poland
1
Libya
1
Bhutan
1
Authors & Publishers
Publication Years
Category
Countries
306
Clinical Guidelines
143
Public Health
90
Key Resources
45
Women & Child Health
40
Pharmacy & Technologies
23
Capacity Building
12
Toolboxes
HIV
199
Mental Health
179
TB
138
AMR
126
COVID-19
54
Pharmacy
46
NCDs
41
Rapid Response
39
NTDs
35
Refugee
25
Ebola & Marburg
22
Planetary Health
22
Conflict
22
Global Health Education
21
Caregiver
18
Disability
16
Health Financing Toolbox
12
Specific Hazards
5
Natural Hazards
5
Zika
5
Polio
4
Cholera
2
Malaria
2
Social Ethics
1
Modelling the health impacts of disruptions to essential health services during COVID-19 Module 1
Several epidemiological models have been created to assess the potential impact of disruptions to essential health services caused by COVID-19 on morbidity and mortality from conditions other than COVI...
Noncommunicable diseases (NCDs) such as cancer, cardiovascular disease, diabetes and chronic respiratory diseases and their risk factors are an increasing public health and development challenge in Kazakhstan. This report provides evidence through three analyses that NCDs reduce economic output and ...
Due to high routine vaccination coverage, overall counts of diphtheria case have significantly declined in the Western Pacific Region recently. However, diphtheria is still prevalent in several countries and areas of the Region and remains a public health issue due to its high case fatality rate.
...
PLoS Negl Trop Dis 13(10): e0007694. In 2005, the World Health Organization (WHO) recognized Chagas disease (CD; Trypanosoma cruzi infection) as a neglected tropical disease (NTD) [1] and included it into the global plan to combat NTDs [2]. The Target 3.3 of the United Nations Sustainable Developmen...
Tokar et al. Health Research Policy and Systems (2019) 17:23 https://doi.org/10.1186/s12961-019-0415-4
In 2016, the risk of premature mortality1 from noncommunicable diseases (NCDs) in Ethiopia was 18.3%. The economic costs of NCDs are significant and are due principally to their impact on the non-health sector (reduced workforce and productivity). In this study, it is estimated that NCDs cost Ethiop...
The new guidelines provide public health guidance on pharmacological agents for managing hyperglycaemia in type 1 and type 2 diabetes for use in primary health-care in low-resource settings. These guidelines update the recommendations for managing hyperglycaemia in the WHO Package of Essential NCD I...
Tackling Tuberculosis in Under-Served Populations: A Resource for TB Control Boards and their partners
The escalating antimicrobial resistance (AMR) pandemic is a global public health threat with extensive health, economic and societal implications. Resistance emerges because of selection pressure from rational and indiscriminate antimicrobial use in human health as well as in the veterinary, agricul...
The seven essential features of practice for scaling up are described with great clarity. They are practical and universal, and encourage local innovation. They include policy, funding and local management structure, as well as working with all possible partners and developing local context adaptati...
13280–13285 / PNAS / September 9, 2008 / vol. 105 / no. 36
The World Health Organization Disability Assessment Schedule (WHODAS 2.0) is a generic assessment instrument developed by WHO to provide a standardized method for measuring health and disability across cultures. It was developed from a comprehensive set of International Classification of Functioning...
This manual summarizes the methodology used to develop WHODAS 2.0 and the findings obtained when the schedule was applied to certain areas of general health, including mental and neurological disorders.
The manual will be useful to any researcher or clinician wishing to use WHODAS 2.0 in their prac...
In an ambitious new era for health development under the 2030 Agenda for Sustainable Development, WHO and
its partners have a solid foundation of success on which to build. Health plays a fundamental role in development
and is the central focus of Sustainable Development Goal 3, “Ensure healthy ...
Lancet Glob Health 2020Published OnlineNovember 27, 2020 https://doi.org/10.1016/S2214-109X(20)30449-6
